Oncolytics Biotech Inc
TSX:ONC

Watchlist Manager
Oncolytics Biotech Inc Logo
Oncolytics Biotech Inc
TSX:ONC
Watchlist
Price: 1.73 CAD -2.81% Market Closed
Market Cap: 153.7m CAD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ONC.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ONC Intrinsic Value
Not Available
Base Case Scenario
Compare ONC to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ONC?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Oncolytics Biotech Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Oncolytics Biotech Inc

Current Assets 18.5m
Cash & Short-Term Investments 16.5m
Receivables 89k
Other Current Assets 1.9m
Non-Current Assets 1.2m
PP&E 1.2m
Efficiency

Free Cash Flow Analysis
Oncolytics Biotech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Oncolytics Biotech Inc

Revenue
0 CAD
Operating Expenses
-33.3m CAD
Operating Income
-33.3m CAD
Other Expenses
1.8m CAD
Net Income
-31.5m CAD
Fundamental Scores

ONC Profitability Score
Profitability Due Diligence

Oncolytics Biotech Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
21/100
Profitability
Score

Oncolytics Biotech Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

ONC Solvency Score
Solvency Due Diligence

Oncolytics Biotech Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
59/100
Solvency
Score

Oncolytics Biotech Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ONC Price Targets Summary
Oncolytics Biotech Inc

Wall Street analysts forecast ONC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ONC is 4.67 CAD with a low forecast of 3.54 CAD and a high forecast of 5.51 CAD.

Lowest
Price Target
3.54 CAD
104% Upside
Average
Price Target
4.67 CAD
170% Upside
Highest
Price Target
5.51 CAD
219% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Oncolytics Biotech Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ONC is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y